Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06611215 · ClinicalTrials.gov registry record · NA
Effect of a Nutritional Supplement on Gut Microbiota in Adults
A NA study, sponsored by Pharmavite.
- Not yet
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT06611215: Clinical Trial NA study, sponsored by Pharmavite.
NCT06611215 is a NA study that has not yet begun recruiting, run by Pharmavite. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06611215, a NA study, has not yet begun recruiting, sponsored by Pharmavite.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
According to International Scientific Association for Probiotics and Prebiotics (ISAPP), a prebiotic is defined as a substrate that is selectively utilized by host microorganisms conferring a health benefit (Gibson et al, 2017). Fibers/ Prebiotics are known to have several beneficial effects on human health via gut. They remain mostly undigested in upper GI and reach colon where they are fermented by resident gut microbiota. This leads to the production of several beneficial metabolites such as short chain fatty acids and others which are implied in human health. The aim of this study is to examine the effects of combinations of two prebiotics on gut microbiota modulation and Quality of Life at two doses.
Primary Outcome
Change in gut microbiota composition defined by percentage abundances of microbes (determined by shotgun sequencing of fecal samples) from baseline to end of intervention (Day 56) in the two prebiotic supplements compared to the corresponding Placebo
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-09-23 |
| Est. Completion | 2025-06-02 |
| Phase | NA |
What is known before NCT06611215 opens enrollment
NCT06611215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06611215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06611215 about?
NCT06611215 is a clinical study titled "Effect of a Nutritional Supplement on Gut Microbiota in Adults". According to International Scientific Association for Probiotics and Prebiotics (ISAPP), a prebiotic is defined as a substrate that is selectively utilized by host microorganisms conferring a health benefit (Gibson et al, 2017). Fibers/ Prebiotics are known to have several beneficial effects on huma...
What is the current status of trial NCT06611215?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-09-23. Estimated completion is 2025-06-02.
What interventions are being tested in trial NCT06611215?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Treatment (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06611215?
This trial is sponsored by Pharmavite, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06611215's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI